174 related articles for article (PubMed ID: 31473097)
1. Corrigendum to "Effect of chlorogenic acid on mast cell-dependent anaphylactic reaction" [Int. Immunopharmacol. 10 (2010) 1135-1141].
Qin HD; Shi YQ; Liu ZH; Li ZG; Wang HS; Wang H; Liu ZP
Int Immunopharmacol; 2019 Nov; 76():105863. PubMed ID: 31473097
[No Abstract] [Full Text] [Related]
2. Corrigendum to "Modulating endoplasmic reticulum stress attenuates mast cell degranulation" [Int. Immunopharmacol. 126 (2024) 111336].
Fan J; Ma L; Xie B; Qiu S; Song S; Tang Z; Wu Y; Huangfu H; Feng Y; Luo X; Yang P
Int Immunopharmacol; 2024 Jun; ():112497. PubMed ID: 38902129
[No Abstract] [Full Text] [Related]
3. Effect of chlorogenic acid on mast cell-dependent anaphylactic reaction.
Qin HD; Shi YQ; Liu ZH; Li ZG; Wang HS; Wang H; Liu ZP
Int Immunopharmacol; 2010 Sep; 10(9):1135-41. PubMed ID: 20620227
[TBL] [Abstract][Full Text] [Related]
4. Corrigendum to "Emodin ameliorates ulcerative colitis by the flagellin-TLR5 dependent pathway in mice" [Int. Immunopharmacol. 59 (2018) 269-275].
Luo S; Deng X; Liu Q; Pan Z; Zhao Z; Zhou L; Luo X
Int Immunopharmacol; 2018 Sep; 62():337. PubMed ID: 29983242
[No Abstract] [Full Text] [Related]
5. Corrigendum to "Asiatic acid inhibits LPS-induced inflammatory response in human gingival fibroblasts" [Int. Immunopharmacol. 50(2017) 313-318].
Hao C; Wu B; Hou Z; Xie Q; Liao T; Wang T; Ma D
Int Immunopharmacol; 2019 Jul; 72():523. PubMed ID: 31080023
[No Abstract] [Full Text] [Related]
6. Corrigendum to 'Protective effect of kobophenol A on nitric oxide-induced cell apoptosis in human osteoblast-like MG-63 cells: Involvement of JNK, NF-κB and AP-1 pathways' [Int. Immunopharmacol. 11 (2011) 1251-1259].
Lee SR; Kwak JH; Park DS; Pyo S
Int Immunopharmacol; 2019 Jan; 66():388. PubMed ID: 30473316
[No Abstract] [Full Text] [Related]
7. Corrigendum to "IDO1: An important immunotherapy target in cancer treatment" [Int. Immunopharmacol. 47 (2017) 70-77].
Li F; Zhang R; Li S; Liu J
Int Immunopharmacol; 2017 Aug; 49():231. PubMed ID: 28457914
[No Abstract] [Full Text] [Related]
8. Corrigendum to "Regulation of fetal hemoglobin expression during hematopoietic stem cell development and its importance in bone metabolism and osteoporosis" [Int. Immunopharmacol. 57 (2018) 112-120].
Kos O; Alexander C; Brandenburg K; Chen Z; Heini A; Heumann D; Khatri I; Mach JP; Rietschel ET; Terskikh A; Ulmer AJ; Waelli T; Yu K; Zähringer U; Gorczynski RM
Int Immunopharmacol; 2018 Jun; 59():413. PubMed ID: 29681496
[No Abstract] [Full Text] [Related]
9. Corrigendum to "Immune-enhancing effects of polysaccharides extracted from Lilium lancifolium Thunb" [Int. Immunopharmacol. 52 (2017) 119-126].
Pan G; Xie Z; Huang S; Tai Y; Cai Q; Jiang W; Sun J; Yuan Y
Int Immunopharmacol; 2018 May; 58():186. PubMed ID: 29599101
[No Abstract] [Full Text] [Related]
10. Corrigendum to "Circulating midkine in children with Henoch-Schönlein purpura: Clinical implications" [Int. Immunopharmacol. (2016) 246-250].
Su Z; Lv X; Liu Y; Zhang J; Guan J; Gai Z
Int Immunopharmacol; 2016 Dec; 41():145. PubMed ID: 27612398
[No Abstract] [Full Text] [Related]
11. Corrigendum to "Asiatic acid from Potentilla chinensis alleviates non-alcoholic fatty liver by regulating endoplasmic reticulum stress and lipid metabolism". [Int. Immunopharmacol. 65 (2018) 256-267].
Wang D; Lao L; Pang X; Qiao Q; Pang L; Feng Z; Bai F; Sun X; Lin X; Wei J
Int Immunopharmacol; 2020 Jul; 84():106291. PubMed ID: 32094005
[No Abstract] [Full Text] [Related]
12. Corrigendum to "Stereocalpin A inhibits the expression of adhesion molecules in activated vascular smooth muscle cells" [Int. Immunopharmacol. 12 (2012) 315-325].
Byeon HE; Park BK; Yim JH; Lee HK; Moon EY; Rhee DK; Pyo S
Int Immunopharmacol; 2019 Jan; 66():389. PubMed ID: 30503384
[No Abstract] [Full Text] [Related]
13. Corrigendum to "Mangiferin corrects the imbalance of Th17/Treg cells in mice with TNBS-induced colitis" [Int. Immunopharmacol. (2016) 220-228].
Lim SM; Jeong JJ; Choi HS; Chang HB; Kim DH
Int Immunopharmacol; 2016 Sep; 38():468. PubMed ID: 27262502
[No Abstract] [Full Text] [Related]
14. Corrigendum to "Melatonin prevents endothelial dysfunction in SLE by activating the nuclear receptor retinoic acid-related orphan receptor-α" [Int. Immunopharmacol. 83 (2020) 106365].
Huang H; Liu X; Chen D; Lu Y; Li J; Du F; Zhang C; Lu L
Int Immunopharmacol; 2020 Sep; 86():106817. PubMed ID: 32736997
[No Abstract] [Full Text] [Related]
15. Corrigendum to "Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function" [Int. Immunopharmacol. (2015) 423-432].
Sun J; Shen X; Dong J; Zhao J; Zuo L; Wang H; Li Y; Zhu W; Gong J; Li J
Int Immunopharmacol; 2016 Jun; 35():341. PubMed ID: 27130814
[No Abstract] [Full Text] [Related]
16. Corrigendum to "Zerumbone enhances the Th1 response and ameliorates ovalbumin-induced Th2 responses and airway inflammation in mice" [Int. Immunopharmacol. 24 (2015) 383-391].
Shieh YH; Huang HM; Ching-Chiung Wang ; Lee CC; Fan CK; Lee YL
Int Immunopharmacol; 2017 Sep; 50():371. PubMed ID: 28751107
[No Abstract] [Full Text] [Related]
17. Corrigendum to "p300 mediates the histone acetylation of ORMDL3 to affect airway inflammation and remodeling in asthma" [Int. Immunopharmacol. 76 (2019) 105885].
Cheng Q; Shang Y; Huang W; Zhang Q; Li X; Zhou Q
Int Immunopharmacol; 2020 Mar; 80():106213. PubMed ID: 31983587
[No Abstract] [Full Text] [Related]
18. Corrigendum to "Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway" [Int. Immunopharmacol. 36 (2016) 132-141].
Yao H; Hu C; Yin L; Tao X; Xu L; Qi Y; Han X; Xu Y; Zhao Y; Wang C; Peng J
Int Immunopharmacol; 2019 Sep; 74():105786. PubMed ID: 31402320
[No Abstract] [Full Text] [Related]
19. Corrigendum to "Sinomenine inhibits fibroblast-like synoviocyte proliferation by regulating α7nAChR expression via ERK/Egr-1 pathway" [Int. Immunopharmacol. 56 (2018) 65-70].
Yi L; Lyu YJ; Peng C; Zhu RL; Bai SS; Liu L; Wang PX; Zhou H; Dong Y
Int Immunopharmacol; 2018 Sep; 62():339. PubMed ID: 30007832
[No Abstract] [Full Text] [Related]
20. Corrigendum to "Rapid infusions of human normal immunoglobulin 50g/l are safe and well tolerated in immunodeficiencies and immune thrombocytopenia" [Int. Immunopharmacol. 44 (2017) 38-42].
Spadaro G; Vultaggio A; Bosi A; Reichert D; Janssen J; Lamacchia D; Nappi L; Pecoraro A; Milito C; Ferraro A; Matucci A; Bacchiarri F; Carrai V; Hibbeler A; Speckman E; Guarnieri C; Bongiovanni S; Quinti I
Int Immunopharmacol; 2018 Apr; 57():201. PubMed ID: 29089244
[No Abstract] [Full Text] [Related]
[Next] [New Search]
